Effect of rituximab on a salivary gland ultrasound score in primary Sjögren’s syndrome: results of the TRACTISS randomised double-blind multicentre substudy

Autor: Fisher, BA, Everett, CC, Rout, J, O'Dwyer, JL, Emery, P, Pitzalis, C, Ng, W-F, Carr, A, Pease, CT, Price, EJ, Sutcliffe, N, Makdissi, J, Tappuni, AR, Gendi, NST, Hall, FC, Ruddock, SP, Fernandez, C, Hulme, CT, Davies, KA, Edwards, CJ, Lanyon, PC, Moots, RJ, Roussou, E, Richards, A, Sharples, LD, Bombardieri, M, Bowman, SJ

Publikováno v: Annals of the Rheumatic Diseases

Objectives To compare the effects of rituximab versus placebo on salivary gland ultrasound (SGUS) in primary Sjögren’s syndrome (PSS) in a multicentre, multiobserver phase III trial substudy.\ud \ud \ud \ud Methods Subjects consenting to SGUS were

Externí odkaz: https://explore.openaire.eu/search/publication?articleId=pmid_dedup__::d9f4a79990416b5a98fb355d2854f32c

Tento výsledek nelze pro nepřihlášené uživatele zobrazit.
K zobrazení výsledku je třeba se přihlásit.

Effect of rituximab on a salivary gland ultrasound score in primary Sjögren's syndrome: results of the TRACTISS randomised double-blind multicentre substudy.

Autor: Fisher BA; National Institute for Health Research (NIHR), Birmingham Biomedical Research Centre, Birmingham, UK.; Rheumatology Research Group, Institute of Inflammation and Ageing, University of Birmingham, Birmingham, UK.; Rheumatology Department, University Hospitals Birmingham NHS Foundation Trust, Birmingham, UK., Everett CC; Leeds Institute for Clinical Trials Research, University of Leeds, Leeds, UK., Rout J; Birmingham Dental Hospital, Birmingham, UK., O'Dwyer JL; Academic Unit of Health Economics, Leeds Institute of Health Sciences, University of Leeds, Leeds, UK., Emery P; Biomedical Research Centre, Leeds Teaching Hospitals NHS Trust, Leeds, UK.; Leeds Institute of Rheumatic and Musculoskeletal Medicine, University of Leeds, Chapel Allerton Hospital, Leeds, UK., Pitzalis C; William Harvey Research Institute, Barts and The London School of Medicine and Dentistry, London, UK., Ng WF; Institute of Cellular Medicine, University of Newcastle, Newcastle-upon-Tyne, UK., Carr A; Newcastle Dental Hospital, Newcastle-upon-Tyne, UK., Pease CT; Biomedical Research Centre, Leeds Teaching Hospitals NHS Trust, Leeds, UK.; Leeds Institute of Rheumatic and Musculoskeletal Medicine, University of Leeds, Chapel Allerton Hospital, Leeds, UK., Price EJ; Great Western Hospital, Swindon, UK., Sutcliffe N; Royal London Hospital, Barts Health NHS Trust, London, UK., Makdissi J; Institute of Dentistry, Barts and The London School of Medicine and Dentistry, Queen Mary University of London, London, UK., Tappuni AR; Institute of Dentistry, Barts and The London School of Medicine and Dentistry, Queen Mary University of London, London, UK., Gendi NST; Basildon and Thurrock University Hospital, Basildon, UK., Hall FC; Department of Clinical Medicine, University of Cambridge, Addenbrookes Hospital, Cambridge, UK., Ruddock SP; Leeds Institute for Clinical Trials Research, University of Leeds, Leeds, UK., Fernandez C; Leeds Institute for Clinical Trials Research, University of Leeds, Leeds, UK., Hulme CT; Academic Unit of Health Economics, Leeds Institute of Health Sciences, University of Leeds, Leeds, UK., Davies KA; Brighton and Sussex Medical School, University of Sussex, Brighton, UK., Edwards CJ; NIHR Wellcome Trust Clinical Research Facility, University Hospital Southampton, Southampton, UK., Lanyon PC; Nottingham University Hospitals NHS Trust, and Nottingham NHS Treatment Centre, Nottingham, UK., Moots RJ; Department of Musculoskeletal Biology, Institute of Ageing and Chronic Disease, University of Liverpool, Liverpool, UK., Roussou E; Barking Havering and Redbridge University Hospitals NHS trust (BHRUT), King George Hospital, Goodmayes, UK., Richards A; Birmingham Dental Hospital, Birmingham, UK., Sharples LD; Department of Medical Statistics, London School of Hygiene and Tropical Medicine, London, UK., Bombardieri M; William Harvey Research Institute, Barts and The London School of Medicine and Dentistry, London, UK., Bowman SJ; National Institute for Health Research (NIHR), Birmingham Biomedical Research Centre, Birmingham, UK.; Rheumatology Research Group, Institute of Inflammation and Ageing, University of Birmingham, Birmingham, UK.; Rheumatology Department, University Hospitals Birmingham NHS Foundation Trust, Birmingham, UK.

Publikováno v: Annals of the rheumatic diseases [Ann Rheum Dis] 2018 Mar; Vol. 77 (3), pp. 412-416. Date of Electronic Publication: 2017 Dec 23.

The DARS (Dopamine Augmented Rehabilitation in Stroke) trial: protocol for a randomised controlled trial of Co-careldopa treatment in addition to routine NHS occupational and physical therapy after stroke.

Autor: Bhakta BB, Hartley S; University of Leeds, Leeds, UK. s.hartley@leeds.ac.uk., Holloway I, Couzens JA, Ford GA, Meads D, Sackley CM, Walker MF, Ruddock SP, Farrin AJ

Publikováno v: Trials [Trials] 2014 Aug 08; Vol. 15, pp. 316. Date of Electronic Publication: 2014 Aug 08.

Development of assays for the detection of photomutagenicity of chemicals during exposure to UV light--I. Assay development.

Autor: Dean SW; Hazleton Microtest, York, UK., Lane M, Dunmore RH, Ruddock SP, Martin CN, Kirkland DJ, Loprieno N

Publikováno v: Mutagenesis [Mutagenesis] 1991 Sep; Vol. 6 (5), pp. 335-41.